Elastomeric Homepump C-Series – A Simple Reliable and Cost Effective Alternative to Electronic Pumps

By August 31, 2018IV Therapy

Elastomeric Homepump C-Series* – a simple, reliable and cost-effective alternative to electronic pumps

Determining the best option for IV infusion can come down to a balance between ease of patient use and the potential for a best-case outcome. One option that meets both requisites is the Avanos Medical elastomeric Homepump C-Series*.

Ease of Patient Use

The Homepump C-Series* is a viable substitute for the more traditional IV infusion electronic pumps. In fact, disposable elastomeric pumps are overwhelmingly preferred by patients over electronic pumps. A number of factors contribute to this preference, and ease of use is at the top of the list.

Patient Outcomes

The Homepump C-Series*, a non-electronic, completely disposable pump, uses elastomeric membranes to create pressure and deliver medication at a pre-set flow rate. The resulting ease of use and clinical accuracy provide the foundation of all Avanos products, and the Homepump C-Series* is no different.

Studies have addressed the benefits of elastomeric pumps in comparison to electronic pumps. The results reveal that disposable, elastomeric pumps are an acceptable alternative and equally or more effective than other traditional methods of pain relief.1,2

Balancing the importance of outcomes and ease of patient use is an essential consideration when selecting the manner of IV infusion therapy. Given the evidence, the Avanos Homepump C-Series* may be a preferred option, both by patients and medical providers.

References

  1. Carro,George, Lawton, Jessica, Harper, Abigail, Palafox, Anna. ” Elastomeric and Electronic Medication Pumps at an Outpatient Cancer Clinic”, Kellogg Cancer Center NorthShore University HealthSystem, Evanston, Illinois, Northshore_dosi-fusger_study.pdf.
  2. Zahnd, Aebi, Rusterholz, Fey, Borner. “A randomized crossover trial assessing patient preference for two different types of portable infusion pump devices “, Annals of Oncology, 10.6 (1999): 727-729.